tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

REPL Stock Latest News

Replimune price target raised to $18 from $16 at JPMorgan
The FlyReplimune price target raised to $18 from $16 at JPMorgan
1M ago
REPL
Replimune Group’s Promising Milestones and Strong Financial Position Drive Buy Rating
PremiumRatings
Replimune Group’s Promising Milestones and Strong Financial Position Drive Buy Rating
2M ago
REPL
Replimune price target raised to $22 from $21 at H.C. Wainwright
PremiumThe Fly
Replimune price target raised to $22 from $21 at H.C. Wainwright
2M ago
REPL
Navigating Uncertainty: Replimune Group’s Strategic Challenges Amid Clinical Trials and Global Risks
PremiumCompany Announcements
Navigating Uncertainty: Replimune Group’s Strategic Challenges Amid Clinical Trials and Global Risks
2M ago
REPL
Replimune price target raised to $19 from $16 at Wedbush
PremiumThe Fly
Replimune price target raised to $19 from $16 at Wedbush
2M ago
REPL
Replimune price target raised to $21 from $18 at Leerink
PremiumThe FlyReplimune price target raised to $21 from $18 at Leerink
2M ago
REPL
Replimune reports Q3 EPS (79c) vs (77c) last year
Premium
The Fly
Replimune reports Q3 EPS (79c) vs (77c) last year
2M ago
REPL
Replimune Group (REPL) Q3 Earnings Cheat Sheet
Premium
Pre-Earnings
Replimune Group (REPL) Q3 Earnings Cheat Sheet
2M ago
REPL
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
INM
IPA
Replimune price target raised to $27 from $18 at BMO Capital
PremiumThe Fly
Replimune price target raised to $27 from $18 at BMO Capital
2M ago
REPL
Replimune price target raised to $21 from $17 at H.C. Wainwright
PremiumThe Fly
Replimune price target raised to $21 from $17 at H.C. Wainwright
2M ago
REPL
Replimune announces BLA acceptance, priority review for RP1
PremiumThe Fly
Replimune announces BLA acceptance, priority review for RP1
2M ago
REPL
Replimune announces RP2 development program advances
PremiumThe FlyReplimune announces RP2 development program advances
3M ago
REPL
Replimune management to meet with Jefferies
Premium
The Fly
Replimune management to meet with Jefferies
3M ago
REPL
Replimune price target raised to $19 from $16 at Jefferies
Premium
The Fly
Replimune price target raised to $19 from $16 at Jefferies
4M ago
REPL
Replimune 6.923M share Spot Secondary priced at $13.00
PremiumThe Fly
Replimune 6.923M share Spot Secondary priced at $13.00
4M ago
REPL
Replimune announces proposed public offering of $125M of shares
PremiumThe Fly
Replimune announces proposed public offering of $125M of shares
4M ago
REPL
Amazon invests $4B more in Anthropic, Gap reports Q3 beat: Morning Buzz
PremiumThe Fly
Amazon invests $4B more in Anthropic, Gap reports Q3 beat: Morning Buzz
4M ago
BA
APG
Replimune price target raised to $18 from $14 at BMO Capital
PremiumThe Fly
Replimune price target raised to $18 from $14 at BMO Capital
4M ago
REPL
Closing Bell Movers: Gap jumps 15% after Q3 earnings beat, guidance raise
PremiumThe FlyClosing Bell Movers: Gap jumps 15% after Q3 earnings beat, guidance raise
4M ago
BGC
GAP
Replimune Group Advances Cancer Treatment with FDA Submission
Premium
Company Announcements
Replimune Group Advances Cancer Treatment with FDA Submission
4M ago
8K
REPL
Replimune submits RP1 BLA to FDA, receives breakthrough therapy designation
Premium
The Fly
Replimune submits RP1 BLA to FDA, receives breakthrough therapy designation
4M ago
REPL

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >